XTX Topco Ltd Cuts Holdings in Senseonics Holdings, Inc. (NYSE:SENS)

XTX Topco Ltd trimmed its holdings in shares of Senseonics Holdings, Inc. (NYSE:SENS) by 76.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 81,918 shares of the company’s stock after selling 259,996 shares during the quarter. XTX Topco Ltd’s holdings in Senseonics were worth $54,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of SENS. First Light Asset Management LLC purchased a new position in Senseonics in the fourth quarter worth $3,366,000. Jane Street Group LLC grew its holdings in Senseonics by 6,694.1% in the fourth quarter. Jane Street Group LLC now owns 6,118,786 shares of the company’s stock worth $3,203,000 after purchasing an additional 6,028,726 shares during the last quarter. Renaissance Technologies LLC purchased a new position in Senseonics in the fourth quarter worth $720,000. Millennium Management LLC grew its holdings in Senseonics by 299.0% in the fourth quarter. Millennium Management LLC now owns 1,088,029 shares of the company’s stock worth $569,000 after purchasing an additional 815,332 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in Senseonics by 9.7% in the fourth quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company’s stock worth $3,354,000 after purchasing an additional 566,704 shares during the last quarter. 12.36% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on SENS. Lake Street Capital raised shares of Senseonics to a “strong-buy” rating in a report on Thursday, July 17th. Wall Street Zen raised shares of Senseonics to a “sell” rating in a report on Monday, May 12th. TD Cowen began coverage on shares of Senseonics in a report on Tuesday, July 15th. They issued a “buy” rating and a $1.25 price target on the stock. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $1.40 price target (up from $1.10) on shares of Senseonics in a report on Tuesday, July 8th. One investment analyst has rated the stock with a sell rating, two have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $1.55.

Senseonics Price Performance

Shares of SENS opened at $0.47 on Friday. The firm has a market capitalization of $309.18 million, a PE ratio of -3.64 and a beta of 0.88. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. Senseonics Holdings, Inc. has a 1-year low of $0.25 and a 1-year high of $1.40. The company’s fifty day moving average price is $0.51 and its 200-day moving average price is $0.65.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.